The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis (Q34654538)

3 August 2017

1 reference

title

The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis (English)

1 reference

3 August 2017

0 references

1 reference

Jean-Michel Dayer

1

1 reference

3 August 2017

publication date

1 March 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

69

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

123-132

1 reference

Collagenase Production by Rheumatoid Synovial Cells: Stimulation by a Human Lymphocyte Factor

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Bone Resorbing Activity in Supernatant Fluid from Cultured Human Peripheral Blood Leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Identification of catabolin, a protein fro synovium which induces degradation of cartilage in organ culture

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Demonstration and characterization of two distinct human leukocytic pyrogens

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Human leukocytic pyrogen: purification and development of a radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s)

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Human collagenase: identification and characterization of an enzyme from rheumatoid synovium in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Collagenolytic activity in amphibian tissues: a tissue culture assay

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Pathogenesis of bone erosions in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Purification and characterization of a 26-kDa competitive inhibitor of interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Anti-interleukin-1 therapy in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

A human inhibitor of tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Isolation and characterization of a tumor necrosis factor binding protein from urine

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Soluble tumor necrosis factor receptors in human inflammatory synovial fluids

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: influence of GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Interleukin-1 receptor antagonist: role in biology

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Human Th1 cells preferentially induce interleukin (IL)-1beta while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Uncoupling of inflammatory and destructive mechanisms in arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Altered susceptibility to collagen-induced arthritis in transgenic mice with aberrant expression of interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Expression and cleavage of tumor necrosis factor-alpha and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

CCR5 is characteristic of Th1 lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

CD40-CD40 ligand (CD154) engagement is required but may not be sufficient for human T helper 1 cell induction of interleukin-2- or interleukin-15-driven, contact-dependent, interleukin-1beta production by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Modulation of soluble and membrane-bound TNF-induced phenotypic and functional changes of human brain microvascular endothelial cells by recombinant TNF binding protein I.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Interleukin-18, rheumatoid arthritis, and tissue destruction

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2802%2900363-9

7 January 2021

10.1016/S1297-319X(02)00363-9

Identifiers

DOI

1 reference

3 August 2017

1 reference